Antibiotic Treatment for Bacterial Conjunctivitis
For uncomplicated bacterial conjunctivitis, use topical fluoroquinolones (moxifloxacin 0.5%) or azithromycin; for contact lens wearers, immediately discontinue lens use and treat with topical fluoroquinolones to cover Pseudomonas; for hyperacute gonococcal conjunctivitis, administer ceftriaxone 1g IM as a single dose plus azithromycin 1g orally for concurrent chlamydial coverage. 1
Standard Bacterial Conjunctivitis
Most cases of bacterial conjunctivitis are self-limiting, resolving in 1-2 weeks without treatment 2. However, topical antibiotics shorten disease duration and reduce contagiousness, allowing earlier return to work or school 3, 2.
Recommended topical antibiotics include:
- Moxifloxacin 0.5% (preferred for rapid bacterial killing and limiting transmission) 4
- Azithromycin ophthalmic solution
- Other fluoroquinolones
The evidence shows moxifloxacin kills Streptococcus pneumoniae faster than older agents like tobramycin, gentamicin, or polymyxin B-trimethoprim, which is clinically relevant for controlling contagious outbreaks 4.
Contact Lens-Associated Conjunctivitis
Critical action: Immediately discontinue contact lens wear 5. Contact lens wearers require aggressive treatment because of the risk of Pseudomonas aeruginosa infection, which can rapidly progress to vision-threatening keratitis 2, 5.
Treatment approach:
- Use topical fluoroquinolones (moxifloxacin or other fourth-generation agents) for Pseudomonas coverage
- Obtain cultures if symptoms are severe or persistent 5
- Evaluate carefully for corneal involvement with slit-lamp examination 5
- Do NOT use corticosteroids until infection is ruled out
Contact lens-related infections represent a diagnostic challenge because early microbial keratitis can mimic benign inflammatory conditions 5. When in doubt, treat as infectious and refer promptly.
Hyperacute Gonococcal Conjunctivitis
This is an ophthalmologic emergency requiring immediate systemic antibiotics due to the risk of rapid corneal perforation and vision loss 1, 6, 7.
Adult treatment regimen (per 2024 AAO guidelines):
- Ceftriaxone 1g IM single dose 1
- PLUS Azithromycin 1g orally single dose (for concurrent chlamydial infection, which occurs in up to 50% of cases) 1
Alternative if ceftriaxone unavailable: Cefixime 400mg orally single dose, though this is less preferred 1.
Clinical recognition features:
- Copious purulent discharge
- Severe conjunctival hyperemia and chemosis
- Periorbital edema
- Pain with eye movements 6
- Rapid onset (hyperacute presentation)
Critical pitfall: Always treat for concurrent chlamydia, as coinfection is common 1. Consider lavage of the eye with saline 1. Obtain sexual history and screen for other sexually transmitted infections 8.
Chlamydial Conjunctivitis
Requires systemic treatment (topical therapy alone is insufficient):
Adult treatment:
- Azithromycin 1g orally single dose, OR
- Doxycycline 100mg orally twice daily for 7 days 1
Pregnant women: Use erythromycin or amoxicillin (avoid doxycycline and fluoroquinolones) 1.
Antibiotic Resistance Considerations
Rising antibiotic resistance is a growing concern 3, 9. Methicillin resistance in ocular Staphylococcus aureus reaches 45.9% in the U.S., with multidrug resistance exceeding 70% among methicillin-resistant isolates 9.
When to obtain cultures:
- Severe or persistent cases 3
- Contact lens wearers with concerning features 5
- Suspected gonococcal or chlamydial infection 1
- Immunocompromised patients 3
- Treatment failures
Key Clinical Distinctions
Bacterial conjunctivitis indicators:
- Mattering and eyelid adherence on waking
- Lack of itching
- No history of recurrent conjunctivitis 2
Gonococcal vs. typical bacterial: